2025-2026 Annual report
2025-2026 Executive team
April 1, 2025 – March 31, 2026
Dr. Craig Earle
Chief Executive Officer
Shari Dworkin
Acting Vice President, Cancer Systems and Innovation (leave coverage)
Erika Nicholson
Vice President, Cancer Systems and Innovation
Andrea Reed
Vice President, Strategic Partnerships
Shelley Tapp
Vice President, Finance and Corporate Services